Published in J Virol on February 03, 2010
Ontogeny of early life immunity. Trends Immunol (2014) 1.35
Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A (2012) 1.08
Viral vectors for vaccine applications. Clin Exp Vaccine Res (2013) 0.98
Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci U S A (2011) 0.91
Alphavirus-based vaccines. Viruses (2014) 0.84
Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice. PLoS One (2010) 0.83
Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges. J Immunol (2014) 0.82
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles. Int J Nanomedicine (2014) 0.82
Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins. J Virol (2013) 0.79
Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity. Clin Vaccine Immunol (2012) 0.78
TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight (2017) 0.78
The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection. Hum Vaccin Immunother (2016) 0.77
The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice. PLoS One (2015) 0.77
Measles virus induces persistent infection by autoregulation of viral replication. Sci Rep (2016) 0.75
Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression. J Virol (2016) 0.75
The Immune Response in Measles: Virus Control, Clearance and Protective Immunity. Viruses (2016) 0.75
Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) (1991) 7.08
Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science (1989) 4.84
Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol (1993) 4.19
Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA (1967) 4.01
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27
Neonatal and early life vaccinology. Vaccine (2001) 3.25
Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr (1977) 2.66
Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet (1991) 2.42
Microneedle-based vaccines. Curr Top Microbiol Immunol (2009) 2.17
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med (2002) 1.88
Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA (1998) 1.83
Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines (2008) 1.77
Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N Engl J Med (1985) 1.68
MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC. Am J Dis Child (1965) 1.66
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56
Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine (2008) 1.55
Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. J Virol (2000) 1.52
Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc Natl Acad Sci U S A (2006) 1.49
Alphavirus vectors and vaccination. Rev Med Virol (2002) 1.40
Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc Natl Acad Sci U S A (1999) 1.38
Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med (1999) 1.35
Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis (1997) 1.29
IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. J Immunol (1999) 1.28
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol (2007) 1.24
Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J Infect Dis (2007) 1.22
Differential mortality by measles vaccine titer and sex. J Infect Dis (1993) 1.20
Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother (2009) 1.16
Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis (2001) 1.16
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A (2005) 1.16
Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling. J Virol (2006) 1.15
Child mortality following standard, medium or high titre measles immunization in West Africa. Int J Epidemiol (1996) 1.12
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine (2007) 1.03
Monkeys in measles research. Curr Top Microbiol Immunol (1995) 1.02
Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein. AIDS Res Hum Retroviruses (2006) 1.01
Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles. J Virol (2005) 1.00
Progress in global measles control and mortality reduction, 2000-2006. MMWR Morb Mortal Wkly Rep (2007) 0.99
Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology (2000) 0.99
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines. Vaccine (2006) 0.99
Loss of maternal measles antibody during infancy in an African city. Int J Epidemiol (1989) 0.98
Measles active and passive immunity in a worldwide perspective. Prog Med Virol (1989) 0.98
An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol (2008) 0.98
Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. Virology (1991) 0.96
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. J Virol (2007) 0.95
Slow clearance of measles virus RNA after acute infection. J Clin Virol (2007) 0.95
Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques. Clin Pharmacol Ther (2007) 0.94
Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J Infect Dis (2007) 0.93
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS One (2008) 0.93
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines. Vaccine (2008) 0.92
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node. J Immunol (2008) 0.92
Detection by hybridization of viral infection of the human central nervous system. Ann N Y Acad Sci (1984) 0.92
Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles. AIDS Res Hum Retroviruses (2006) 0.90
Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus. Clin Vaccine Immunol (2008) 0.89
A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge. Vaccine (2006) 0.87
Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial. Vaccine (2009) 0.87
Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques. Clin Vaccine Immunol (2008) 0.86
Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge. J Infect Dis (2003) 0.83
Establishment and characterisation of murine cells constitutively expressing the fusion, nucleoprotein and matrix proteins of measles virus. J Virol Methods (1993) 0.83
Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol (2009) 0.81
Long-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles. Scand J Immunol (2007) 0.80
Loss of maternally-acquired measles antibody during infancy in Ilorin, Nigeria. J Trop Pediatr (1995) 0.78
Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Virology (2006) 0.77
Detection of measles virus genome in lymphocytes from asymptomatic healthy children. J Med Virol (2001) 0.76
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke (2003) 4.13
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med (2005) 3.38
Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol (2002) 2.55
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Measles. Lancet (2011) 2.37
Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990 to 2001. Med J Aust (2003) 2.23
Global measles elimination. Nat Rev Microbiol (2006) 2.21
Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust (2007) 2.20
Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke (2003) 2.17
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol (2012) 2.14
Adverse drug events and medication errors in Australia. Int J Qual Health Care (2003) 2.03
MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer (2008) 2.01
How valid are self-reported height and weight? A comparison between CATI self-report and clinic measurements using a large cohort study. Aust N Z J Public Health (2006) 1.97
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care (2013) 1.93
The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med (2002) 1.92
The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innov (2006) 1.91
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis (2007) 1.89
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Luciferase imaging of a neurotropic viral infection in intact animals. J Virol (2003) 1.83
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood (2009) 1.83
Sickle cell disease: the neurological complications. Ann Neurol (2002) 1.77
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer (2010) 1.75
Clinical outcome of hemoperfusion in poisoned patients. Blood Purif (2010) 1.72
Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques. AIDS (2012) 1.68
Serum total antioxidant statuses of survivors and nonsurvivors after acute paraquat poisoning. Clin Toxicol (Phila) (2009) 1.67
Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem (2002) 1.60
Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis (2013) 1.57
BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. Dev Cell (2003) 1.56
Organized stroke care. Stroke (2006) 1.56
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood (2013) 1.52
Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis (2004) 1.51
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood (2006) 1.45
The sulfurtransferase activity of Uba4 presents a link between ubiquitin-like protein conjugation and activation of sulfur carrier proteins. Biochemistry (2008) 1.44
Association between plasma paraquat level and outcome of paraquat poisoning in 375 paraquat poisoning patients. Clin Toxicol (Phila) (2008) 1.42
Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol (2006) 1.39
A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat Med (2003) 1.39
Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis (2007) 1.38
REACH: clinical feasibility of a rural telestroke network. Stroke (2005) 1.38
Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis (2010) 1.37
Comparison between kidney and hemoperfusion for paraquat elimination. J Korean Med Sci (2009) 1.35
Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis (2002) 1.31
Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke (2006) 1.31
Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens (2010) 1.29
Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis (2008) 1.27
Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein. J Virol (2004) 1.27
Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. J Cell Biol (2005) 1.25
Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro. J Virol (2005) 1.25
The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol Dial Transplant (2008) 1.24
Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J Infect Dis (2007) 1.22
Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo. Toxicol Ind Health (2003) 1.22
Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol (2002) 1.22
Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology (2011) 1.21
Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J Virol (2007) 1.21
Do people with risky behaviours participate in biomedical cohort studies? BMC Public Health (2006) 1.20
Measles: immune suppression and immune responses. Int J Biochem Cell Biol (2004) 1.18
Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis (2002) 1.18
Telestroke: extending stroke expertise into underserved areas. Lancet Neurol (2006) 1.17
Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion. Hum Gene Ther (2002) 1.17
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis (2009) 1.17
Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann Neurol (2004) 1.16
Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol (2003) 1.16
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A (2005) 1.16
Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection. Proc Natl Acad Sci U S A (2008) 1.15
Role for nsP2 proteins in the cessation of alphavirus minus-strand synthesis by host cells. J Virol (2006) 1.15
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. J Neurochem (2007) 1.15
Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol (2003) 1.15
Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis (2002) 1.14
Genetic predictors for stroke in children with sickle cell anemia. Blood (2011) 1.12
Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci U S A (2006) 1.12
Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology (2010) 1.12
Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model. Breast Cancer Res (2004) 1.10
Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J Neuroimmunol (2002) 1.10
Paraquat intoxication in subjects who attempt suicide: why they chose paraquat. Korean J Intern Med (2009) 1.10
Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm. J Biol Chem (2003) 1.10
Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J Virol (2009) 1.09
A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med (2008) 1.09
Central obesity is associated with nonatopic but not atopic asthma in a representative population sample. J Allergy Clin Immunol (2006) 1.09
Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A (2012) 1.08
Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J Neurovirol (2003) 1.08
Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke (2004) 1.08
A systematic review of home-based childhood obesity prevention studies. Pediatrics (2013) 1.07
Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis (2004) 1.07